Target Price | $335.74 |
Price | $279.77 |
Potential | 20.01% |
Number of Estimates | 27 |
27 Analysts have issued a price target Lululemon Athletica 2026 . The average Lululemon Athletica target price is $335.74. This is 20.01% higher than the current stock price. The highest price target is $500.00 78.72% , the lowest is $194.00 30.66% . | |
A rating was issued by 35 analysts: 19 Analysts recommend Lululemon Athletica to buy, 13 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lululemon Athletica stock has an average upside potential 2026 of 20.01% . Most analysts recommend the Lululemon Athletica stock at Purchase. |
29 Analysts have issued a sales forecast Lululemon Athletica 2026 . The average Lululemon Athletica sales estimate is $11.2b . This is 5.70% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $11.5b 8.29% , the lowest is $10.4b 1.31% .
This results in the following potential growth metrics:
2025 | $10.6b | 10.07% |
---|---|---|
2026 | $11.2b | 5.70% |
2027 | $12.0b | 7.42% |
2028 | $12.7b | 5.79% |
2029 | $13.8b | 8.19% |
2030 | $14.8b | 7.33% |
24 Analysts have issued an Lululemon Athletica EBITDA forecast 2026. The average Lululemon Athletica EBITDA estimate is $3.0b . This is 0.81% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.1b 3.60% , the lowest is $2.5b 17.01% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $2.9b | 13.89% |
---|---|---|
2026 | $3.0b | 1.26% |
2027 | $3.1b | 5.53% |
2028 | $3.4b | 6.72% |
2029 | $3.8b | 12.09% |
2030 | $4.1b | 9.92% |
2025 | 27.83% | 3.47% |
---|---|---|
2026 | 26.66% | 4.19% |
2027 | 26.19% | 1.76% |
2028 | 26.42% | 0.88% |
2029 | 27.37% | 3.60% |
2030 | 28.03% | 2.41% |
10 Lululemon Athletica Analysts have issued a net profit forecast 2026. The average Lululemon Athletica net profit estimate is $1.8b . This is 2.24% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.9b 6.16% , the lowest is $1.6b 10.21% .
This results in the following potential growth metrics and future Net Margins:
2025 | $1.8b | 20.00% |
---|---|---|
2026 | $1.8b | 1.96% |
2027 | $2.0b | 9.52% |
2028 | $2.1b | 3.80% |
2029 | $2.6b | 27.76% |
2030 | $2.9b | 11.25% |
2025 | 16.77% | 9.02% |
---|---|---|
2026 | 16.18% | 3.51% |
2027 | 16.49% | 1.92% |
2028 | 16.18% | 1.88% |
2029 | 19.11% | 18.11% |
2030 | 19.81% | 3.66% |
10 Analysts have issued a Lululemon Athletica forecast for earnings per share. The average Lululemon Athletica EPS is $14.93 . This is 2.26% higher than earnings per share in the financial year 2025. The highest EPS forecast is $15.50 6.16% , the lowest is $13.11 10.21% .
This results in the following potential growth metrics and future valuations:
2025 | $14.64 | 20.00% |
---|---|---|
2026 | $14.93 | 1.98% |
2027 | $16.35 | 9.51% |
2028 | $16.97 | 3.79% |
2029 | $21.68 | 27.75% |
2030 | $24.12 | 11.25% |
Current | 19.17 | 34.10% |
---|---|---|
2026 | 18.74 | 2.24% |
2027 | 17.11 | 8.70% |
2028 | 16.49 | 3.62% |
2029 | 12.90 | 21.77% |
2030 | 11.60 | 10.08% |
Based on analysts' sales estimates for 2026, the Lululemon Athletica stock is valued at an EV/Sales of 2.97 and an P/S ratio of 3.00 .
This results in the following potential growth metrics and future valuations:
Current | 3.14 | 31.14% |
---|---|---|
2026 | 2.97 | 5.50% |
2027 | 2.76 | 6.91% |
2028 | 2.61 | 5.47% |
2029 | 2.41 | 7.57% |
2030 | 2.25 | 6.83% |
Current | 3.17 | 31.71% |
---|---|---|
2026 | 3.00 | 5.39% |
2027 | 2.80 | 6.91% |
2028 | 2.64 | 5.47% |
2029 | 2.44 | 7.57% |
2030 | 2.28 | 6.83% |
Lululemon Athletica...
Analyst | Rating | Action | Date |
---|---|---|---|
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 30 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | Apr 28 2025 |
Goldman Sachs |
Neutral
➜
Neutral
|
Unchanged | Apr 22 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 14 2025 |
Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Apr 11 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Apr 10 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | Apr 09 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 30 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Apr 28 2025 |
Unchanged
Goldman Sachs:
Neutral
➜
Neutral
|
Apr 22 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 14 2025 |
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Apr 11 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Apr 10 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
Apr 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.